Global Pancreatitis Market
Market Size in USD Billion
CAGR :
% 
USD
10.29 Billion
USD
16.03 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 10.29 Billion |
 Market Size (Forecast Year) |
USD 16.03 Billion |
 CAGR |
% |
| Major Markets Players |
Global Pancreatitis Market Segmentation, By Type (Acute Pancreatitis, Chronic Pancreatitis), Causes (Gall Stones, Alcohol, Drugs, Others), Treatment (Analgesics, Intravenous (IV) Fluids, Gallbladder Surgery, Endoscopic Retrograde Cholangiopancreatography (ERCP), Others), Route of Administration (Oral, Parenteral, Others), Diagnosis (Blood Tests, Abdominal Ultrasound, Computerized tomography (CT) scan, Magnetic resonance imaging (MRI), Endoscopic Ultrasound, Stool tests, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
Pancreatitis Market Analysis
Every year, over 275,000 people in the United States are hospitalized to the hospital with acute pancreatitis, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pancreatitis occurs when the pancreas becomes inflamed and irritated (swollen). It isn't a common ailment. Gallstones or excessive alcohol consumption are the most frequent causes. The disease can appear unexpectedly or develop over time, resulting in severe harm. Pancreatitis treatment may involve intravenous (IV) fluids, pain medication, and other medications.
Pancreatitis Market Size
Global pancreatitis market size was valued at USD 10.29 billion in 2024 and is projected to reach USD 16.03 billion by 2032, with a CAGR of 5.70% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Pancreatitis Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Allergan (Ireland), AbbVie Inc. (U.S.), Abbott (U.S.), Bausch Health Companies Inc. (Canada) |
|
Market Opportunities |
|
Pancreatitis Market Definition
Pancreatitis is characterized by the inflammation of the pancreas. The pancreas is located in the upper belly, nestled below the stomach. The pancreas generates digestive enzymes as well as hormones that assist regulate sugar metabolism (glucose). Fluids and nourishment are either intravenously (IV) or through a nasogastric feeding tube that passes straight from your nose to your stomach in the treatment of acute or chronic pancreatitis. Medication such as analgesics assist with pain management. Complications usually demand surgery including gallbladder surgery, endoscopic retrograde cholangiopancreatography (ERCP)
Pancreatitis Market Dynamics
Drivers
- High prevalence rate of acute pancreatitis
The rise in prevalence rate of acute pancreatitis across the globe will act as a major driver that will result in the expansion of the growth rate of the market. Acute pancreatitis is caused by gallstones and high alcohol consumption, especially in the younger population. According to an article published in the World Journal of Clinical Cases- Evaluation and management of acute pancreatitis in 2019, gallstones are the most common cause of acute pancreatitis (AP), accounting for 28 percent to 38 percent of all cases, while alcohol consumption is the second most common cause, accounting for 19 percent to 41 percent of all acute pancreatitis cases. The increased number of patients with gallstones raises the risk of acute pancreatitis.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of pancreatitis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
- Rising incidences of diabetes
The increasing incidences of diabetes is expected to enhance the market’s growth rate. Pancreatitis can harm insulin-producing cells. Insulin is a hormone produced by the pancreas that helps to regulate blood sugar levels. When pancreatitis destroys these cells, roughly 45 percent of persons with chronic pancreatitis develop diabetes.
Furthermore, surging number of government initiatives to spread awareness and increasing number of geriatric population will result in the expansion of pancreatitis market. Along with this, changing lifestyle of people and growing government favourable initiatives will enhance the growth rate of the market. Also, rising prevalence of pancreatic cancer as well as obesity will propel the growth rate of market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the pancreatitis market growth.
Moreover, the market's growth is fueled by investment for the development of advanced technologies and increase in the number of emerging markets. These factors will provide beneficial opportunities for the pancreatitis market growth.
Restraints/Challenges
On the other hand, the high cost associated with the treatment will obstruct the growth rate of pancreatitis market during the forecast period of 2025-2032. The lack of healthcare infrastructure in developing economies and strict regulatory scenario will challenge the pancreatitis market. Additionally, lack of awareness among people and poor reimbursement policies will act as restrain and further impede the growth rate of market during the forecast period of 2025-2032.
This pancreatitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pancreatitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Pancreatitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Pancreatitis Market Scope
The pancreatitis market is segmented on the basis of type, causes, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Acute Pancreatitis
- Chronic Pancreatitis
Causes
- Gall Stones
- Alcohol
- Drugs
- Others
Treatment
- Analgesics
- Intravenous (IV) Fluids
- Gallbladder Surgery
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Others
Diagnosis
- Blood Tests
- Abdominal Ultrasound
- Computerized Tomography (CT) Scan
- Magnetic Resonance Imaging (MRI)
- Endoscopic Ultrasound
- Stool Tests
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Pancreatitis Market Regional Analysis
The pancreatitis market is analyzed and market size insights and trends are provided by country, type, causes, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.
The countries covered in the pancreatitis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the pancreatitis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing demand for specific treatment and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.
Asia-Pacific is expected to be the fastest growing region during the forecast period of 2025-2032 due to growing cases of pancreatitis in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Pancreatitis Market Share
The pancreatitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pancreatitis market.
Pancreatitis Market Leaders Operating in the Market Are:
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Baxter (U.S.)
- Bayer AG (Germany)
- Eli Lilly and Company (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Allergan (Ireland)
- AbbVie Inc. (U.S.)
- Abbott (U.S.)
- Bausch Health Companies Inc. (Canada)
Latest Developments in Pancreatitis Market
- In January 2021, Trevena, Inc. had announced the launch of opiod based medicine named Olinvyk (oliceridine) for the treatment of acute pain in adults. Olinvyk (oliceridine) was approved by FDA in August, 2020. OLINVYK contains oliceridine, an opioid-like Schedule II restricted narcotic with a significant potential for abuse
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
